Arterial Pressure Derivative Analysis for Reliable Autoregulation Monitoring

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for monitoring cerebral autoregulation status are inaccurate due to noise and morphological anomalies in blood pressure signals, leading to unreliable determination of mean arterial pressure (MAP) values, which can result in inappropriate cerebral blood flow and potential brain injuries.

Innovation Solution

Determine characteristic arterial pressure (CAP) values based on derivatives of blood pressure waveforms, such as the maximum or minimum of the first derivative, to provide a more reliable indicator of blood pressure over time, which is less susceptible to noise and morphological anomalies.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If mean arterial pressure (MAP) values are used to monitor cerebral autoregulation status, then the monitoring can be performed, but the accuracy is compromised due to noise and morphological anomalies in blood pressure signals

Engineering Contradiction:
Improvereliability of autoregulation monitoringVSAvoidprecision of blood pressure measurement
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The patent extracts the characteristic arterial pressure (CAP) value from the blood pressure waveform by identifying specific features (maximum or minimum of the first derivative). This extracted CAP value serves as a reliable indicator of arterial pressure while being less susceptible to noise and morphological anomalies compared to traditional MAP calculations, thereby resolving the contradiction between measurement precision and reliability.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the parameter used for blood pressure monitoring from traditional MAP (calculated from systolic and diastolic pressures) to CAP (derived from the maximum or minimum of the first derivative of the waveform). This parameter change transforms the measurement approach to be more robust against noise and morphological variations, simultaneously improving both precision and reliability of autoregulation monitoring.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If traditional blood pressure monitoring methods are used, then the monitoring process is simple, but noise and morphological anomalies lead to inaccurate CAP determination

Engineering Contradiction:
Improveprecision of arterial pressure determinationVSAvoidnoise sensitivity
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent converts the harmful effect of noise and morphological anomalies into a benefit by using the first derivative of the blood pressure waveform. The maximum or minimum of this derivative provides a robust indicator (CAP value) that is actually less sensitive to noise than traditional MAP measurements, transforming the problem of noise sensitivity into an advantage for precise arterial pressure determination.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Reliability

If inaccurate blood pressure values are used, then the monitoring can proceed, but inappropriate cerebral blood flow may occur leading to brain injuries

Engineering Contradiction:
Improvereliability of cerebral blood flow controlVSAvoidrisk of brain injury
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent establishes a feedback mechanism where the CAP value, derived from the blood pressure waveform, is used to determine cerebral autoregulation status. This feedback information can then guide clinical decisions to maintain appropriate cerebral blood flow within the autoregulation range, preventing both ischemia and hyperemia, thereby reducing the risk of brain injuries while improving reliability of blood flow control.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS12484861B2Determining arterial pressures
Publication Date: 2025.12.02 COVIDIEN LP
  • US12484861B2 patent drawing
  • US12484861B2 patent drawing
  • US12484861B2 patent drawing

AI summary

An example autoregulation monitoring system includes processing circuitry configured to receive a blood pressure signal indicative of a blood pressure of a patient; determine a derivative of at least a portion of the blood pressure signal; determine, based on the derivative, a characteristic arterial pressure (CAP) value; determine, based on the CAP value, an autoregulation value of the patient; and output a signal indicative of the autoregulation value of the patient.